Literature DB >> 12749300

IFN-alpha: therapeutic options in HIV and HIV/HCV, HIV/HBV dual infection.

H Jablonowski1.   

Abstract

The antiviral effects of interferon-alpha (IFN-alpha) are well documented for the treatment of hepatitis B or C infections, whereas antiretroviral effects for treatment of HIV-1 infection have been investigated up to now only in small-sized preclinical studies. New preclinical and clinical data on IFN-alpha for HIV, HCV, HBV and especially on co-infections of HIV with HCV or HBV were presented at a symposium of the ConVir conference 2002. This short paper summarizes the presented data on IFN-alpha treatment for HIV and/or HCV or HBV infections.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12749300

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  1 in total

1.  A novel type II membrane receptor up-regulated by IFN-alpha in fibroblasts functions in cell proliferation through the JAK-STAT signalling pathway.

Authors:  L-D Liu; C-H Dong; H-J Shi; H-L Zhao; L-C Wang; S-H Ma; Q-H Li
Journal:  Cell Prolif       Date:  2006-04       Impact factor: 6.831

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.